Chronic endothelin A receptor blockade attenuates contribution of sympathetic nervous system to salt hypertension development in adult but not in young Dahl rats

Acta Physiologica - Trang n/a-n/a - 2012
Josef Zicha1, Z Dobešová1, Jaroslav Kuneš1, Ivana Vaněčková1
1Center for Experimental Cardiovascular Research, Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic

Tóm tắt

Từ khóa


Tài liệu tham khảo

Ammarguellat, 2001, Myocardial fibrosis in DOCA-salt hypertensive rats: effect of endothelin ETA receptor antagonism, Circulation, 103, 319, 10.1161/01.CIR.103.2.319

Barton, 2008, Endothelin: 20 years from discovery to therapy, Can J Physiol Pharmacol, 86, 485, 10.1139/Y08-059

Barton, 1998, ETA receptor blockade prevents increased tissue endothelin-1, vascular hypertrophy, and endothelial dysfunction in salt-sensitive hypertension, Hypertension, 31, 499, 10.1161/01.HYP.31.1.499

Barton, 2000, Dysfunctional renal nitric oxide synthase as a determinant of salt-sensitive hypertension: mechanisms of renal artery endothelial dysfunction and role of endothelin for vascular hypertrophy and glomerulosclerosis, J Am Soc Nephrol, 11, 835, 10.1681/ASN.V115835

Callera, 2003, ETA receptor blockade decreases vascular superoxide generation in DOCA-salt hypertension, Hypertension, 42, 811, 10.1161/01.HYP.0000088363.65943.6C

Dahl, 1968, Effects of chronic excess salt ingestion. Modification of experimental hypertension in the rat by variations in the diet, Circ Res, 22, 11, 10.1161/01.RES.22.1.11

Dobešová, 2002, The altered balance between sympathetic nervous system and nitric oxide in salt hypertensive Dahl rats: ontogenetic and F2 hybrid studies, J Hypertens, 20, 945, 10.1097/00004872-200205000-00030

Doucet, 1996, Endothelin antagonists in salt-dependent hypertension associated with renal insufficiency, J Cardiovasc Pharmacol, 27, 643, 10.1097/00005344-199605000-00005

Fink, 2000, Mechanisms of increased venous smooth muscle tone in desoxycorticosterone acetate-salt hypertension, Hypertension, 35, 464, 10.1161/01.HYP.35.1.464

Hojná, 2007, The participation of brain NO synthase in blood pressure control of adult spontaneously hypertensive rats, Mol Cell Biochem, 297, 21, 10.1007/s11010-006-9318-0

Ikeda, 1999, Pathophysiological roles of endothelin-1 in Dahl salt-sensitive hypertension, Hypertension, 34, 514, 10.1161/01.HYP.34.3.514

Kassab, 1998, Endothelin-A receptor antagonism attenuates the hypertension and renal injury in Dahl salt-sensitive rats, Hypertension, 31, 397, 10.1161/01.HYP.31.1.397

Kohan, 2010, Endothelin, hypertension and chronic kidney disease: new insights, Curr Opin Nephrol Hypertens, 19, 134, 10.1097/MNH.0b013e328335f91f

Kuneš, 2002, Altered balance of main vasopressor and vasodepressor systems in rats with genetic hypertension and hypertriglyceridaemia, Clin Sci (Lond), 102, 269, 10.1042/CS20010214

Minami, 1995, Contribution of vascular nitric oxide to basal blood pressure in conscious spontaneously hypertensive rats and normotensive Wistar Kyoto rats, Clin Sci (Lond), 89, 177, 10.1042/cs0890177

Okada, 1994, Antihypertensive effects of BQ-123, a selective endothelin ETA receptor antagonist, in spontaneously hypertensive rats treated with DOCA-salt, Eur J Pharmacol, 259, 339, 10.1016/0014-2999(94)90665-3

Okada, 2000, Marked reduction of mortality in salt-loaded Dahl salt-sensitive rats by the new, selective endothelin ETA receptor antagonist, J-105859, J Hypertens, 18, 1815, 10.1097/00004872-200018120-00016

Opočenský, 2006, Late-onset endothelin-A receptor blockade reduces podocyte injury in homozygous Ren-2 rats despite severe hypertension, Hypertension, 48, 965, 10.1161/01.HYP.0000245117.57524.d6

Park, 2001, ETA receptor antagonist prevents blood pressure elevation and vascular remodeling in aldosterone-infused rats, Hypertension, 37, 1444, 10.1161/01.HYP.37.6.1444

Paulis, 2007, Nifedipine-sensitive noradrenergic vasoconstriction is enhanced in spontaneously hypertensive rats: the influence of chronic captopril treatment, Acta Physiol (Oxf), 191, 255, 10.1111/j.1748-1716.2007.01737.x

Rossi, 2004, Neuronal nitric oxide synthase activity in the paraventricular nucleus buffers central endothelin-1-induced pressor response and vasopressin secretion, J Cardiovasc Pharmacol, 44, S283, 10.1097/01.fjc.0000166275.32421.c6

Rothermund, 2002, Endothelin-A receptor blockade prevents left ventricular hypertrophy and dysfunction in salt-sensitive experimental hypertension, Circulation, 106, 2305, 10.1161/01.CIR.0000038703.78148.54

Rothermund, 2003, Nephroprotective effects of the endothelin ETA receptor antagonist darusentan in salt-sensitive genetic hypertension, Eur J Pharmacol, 468, 209, 10.1016/S0014-2999(03)01714-X

Schiffrin, 2001, Role of endothelin-1 in hypertension and vascular disease, Am J Hypertens, 14, 83S, 10.1016/S0895-7061(01)02074-X

Schnackenberg, 1998, Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic: role of nitric oxide, Hypertension, 32, 59, 10.1161/01.HYP.32.1.59

d'Uscio, 1997, Structure and function of small arteries in salt-induced hypertension: effects of chronic endothelin-subtype-A-receptor blockade, Hypertension, 30, 905, 10.1161/01.HYP.30.4.905

Vaněčková, 2006, Early-onset endothelin receptor blockade in hypertensive heterozygous Ren-2 rats, Vascul Pharmacol, 45, 163, 10.1016/j.vph.2006.05.003

Zicha, 1990, Kinetics of Na+ and K+ transport in red blood cells of Dahl rats. Effects of age and salt, Hypertension, 15, 612, 10.1161/01.HYP.15.6.612

Zicha, 1999, Ontogenetic aspects of hypertension development: analysis in the rat, Physiol Rev, 79, 1227, 10.1152/physrev.1999.79.4.1227

Zicha, 1986, Experimental hypertension in young and adult animals, Hypertension, 8, 1096, 10.1161/01.HYP.8.12.1096

Zicha, 1987, Sodium pump activity in young and adult salt hypertensive Dahl rats, Klin Wochenschr, 65, 76

Zicha, 1989, Antidiuretic and pressor actions of vasopressin in age-dependent DOCA-salt hypertension, Am J Physiol, 256, R138

Zicha, 2001, Relative deficiency of nitric oxide-dependent vasodilation in salt-hypertensive Dahl rats: the possible role of superoxide anions, J Hypertens, 19, 247, 10.1097/00004872-200102000-00011

Zicha, 2006, Antihypertensive mechanisms of chronic captopril or N-acetylcysteine treatment in l-NAME hypertensive rats, Hypertens Res, 29, 1021, 10.1291/hypres.29.1021